[go: up one dir, main page]

PRATAPSINH, 2015 - Google Patents

" RELATIVE EFFICACIES OF DIFFERENCES HORMONAL THERAPEUTIC APPROACHES IN REPEAT BREEDING DAIRY ANIMALS

PRATAPSINH, 2015

View PDF
Document ID
5892570076873871238
Author
PRATAPSINH P
Publication year

External Links

Snippet

Department of Animal Reproduction Gynaecology and Obstetrics College of Veterinary Science and Animal Husbandry Anand Agricultural University, Anand-388 001 This study was carried out in villages of Amul as well as Panchamrut milk shed areas of Gujarat on 80 …
Continue reading at krishikosh.egranth.ac.in (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Similar Documents

Publication Publication Date Title
Ghuman et al. Fertility response using three estrus synchronization regimens in lactating anestrous buffaloes
Murugavel et al. Luteal activity at the onset of a timed insemination protocol affects reproductive outcome in early postpartum dairy cows
Kharche et al. Dose dependent effect of GnRH analogue on pregnancy rate of repeat breeder crossbred cows
CN114681099A (en) Processing method for improving synchronous estrus-timing insemination effect of buffalo in summer
Polasek et al. Impact of a progesterone-releasing intravaginal device and inflammatory reaction on ovarian activity in embryo-recipient anestrus mares
Alnimer et al. Applying variations of the Ovsynch protocol at the middle of the estrus cycle on reproductive performance of lactating dairy cows during summer and winter
Atabay et al. IMPROVED PREGNANCY IN WATER BUFFALOES THROUGH SYNCHRONIZATION OF OVULATION AND FIXED TIME ARTIFICIAL INSEMINATION TECHNIQUE.
Masello et al. Intravaginal instillation of prostaglandin F2α was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows
PRATAPSINH " RELATIVE EFFICACIES OF DIFFERENCES HORMONAL THERAPEUTIC APPROACHES IN REPEAT BREEDING DAIRY ANIMALS
Palomares et al. Oxytocin treatment immediately after calving does not reduce the incidence of retained fetal membranes or improve reproductive performance in crossbred Zebu cows
Lymberopoulos et al. Oestrous synchronization under range conditions in dairy goats treated with different PGF2α doses during the transitional period in Greece
Ghuman et al. Fertility response with four estrus synchronization regimens in prepubertal buffalo heifers
AM et al. Therapeutic effect of single over-dose of PGF2α on typical postpartum anestrus in dairy cows
Singh thesis
Hussain EFFECT OF EXOGENOUS PROGESTERONE IMPLANTS IN POSTPARTUM CATTLE WITH AN EXTENDED POSTPARTUM ANESTRUS INTERVAL
SHRIPATI FERTILITY OF SEXED SEMEN IN OVSYNCH AND DOUBLE PG OVSYNCH PROTOCOLS IN BUFFALOES
Ravikumar Efficacy of oxytocin and prostaglandins administered at the time of artificial insemination on conception rate of estrus and ovulation synchronized repeat breeder cows
Puck Synchronization Protocols Utilizing Progesterone Implants Associated with Estrus Expression, Vaginal Microbiome, and Immune Response in Beef Cattle
Kour STUDY ON EFFECT OF CIDR INSERTION DURING EARLY POST-PARTUM PHASE ON REPRODUCTIVE EFFICIENCY IN DAIRY COWS
RAMESHLAL MASTER OF VETERINARY SCIENCE
GOPALBHAI STUDIES ON MAJOR INFERTILITY PROBLEMS, THEIR DIAGNOSIS AND THERAPEUTIC MANAGEMENT IN BUFFALOES UNDER FIELD CONDITIONS
SATISH INDUCTION OF OVARIAN CYCLICITY IN POSTPARTUM ANESTRUS INDIGENOUS COWS USING CIDR BASED HORMONAL PROTOCOLS
Dash et al. Serum hormonal profile of post-partum anestrous buffaloes induced with double synch and estra double synch protocol
Salam et al. COMPARATIVE EFFICACY OF TWO HORMONAL TREATMENTS FOR OESTRUS INDUCTION IN ANOESTRUS CROSSBRED COWS
NAIKOO Monitoring Postpartum Reproductive Performance in Kankrej Cows through Clinical Diagnosis, Blood Profile and Hormonal Therapy